SWEENEY STATEMENT ON BEIGENE DECISION TO CONSTRUCT NEW MANUFACTURING AND R&D FACILITY IN HOPEWELL

August 3, 2021

Trenton – Senate President Steve Sweeney issued the following statement on today’s announcement by the biotech firm BeiGene that it will open a major new facility in Hopewell:

“I am thrilled to see that BeiGene, an international biotech company, has chosen New Jersey for its new, state-of-the art manufacturing and clinical research and development operations. This will not only create hundreds of new jobs, but also further cement our state’s well-earned reputation as a hub for the life sciences industry, including for cancer research.

“BeiGene’s commitment is a testament to New Jersey’s continued ability to attract cutting-edge, growing firms that have a global impact. We look forward to seeing their new facility open at the Princeton West Innovation Campus in Hopewell, and seeing BeiGene’s continued success.”